Epidermal differentiation complex (locus 1q21) gene expression in head and neck cancer and normal mucosa

Folia Histochemica et Cytobiologica

Volumn 52, Issue 2, 2014, Pages 79-89

  Tyszkiewicz, Tomasz ^a   Jarzab, Michal ^a   Szymczyk, Cezary ^a   Kowal, Monika ^a   Krajewska, Jolanta ^a   Jaworska, Magdalena ^a   Fraczek, Marcin ^b   Krajewska, Anna ^c   Hadas, Ewa ^c   Swierniak, Michal ^a,e   Markowski, Jaroslaw ^c   Lange, Dariusz ^a   Poltorak, Stanislaw ^a   Wiench, Malgorzata ^d   Krecicki, Tomasz ^b   Jarzab, Jerzy ^c   Maciejewski, Adam ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c MEDICAL UNIVERSITY OF SILESIA   (Poland)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Epidermal differentiation complex; Gene expression; HNSCC; Laryngeal cancer; LCE3D; Microarrays; Oral SCC; QPCR; S100 genes

Indexed keywords

ADULT; ARTICLE; DOWN REGULATION; FEMALE; GENE LOCUS; GENE OVEREXPRESSION; GENETIC ANALYSIS; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; LARYNX CANCER; LCE3D GENE; MAJOR CLINICAL STUDY; MALE; MARKER GENE; MOUTH CANCER; MOUTH CAVITY; MOUTH MUCOSA; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; S100A1 GENE; S100A10 GENE; S100A11 GENE; S100A12 GENE; S100A16 GENE; S100A2 GENE; S100A3 GENE; S100A4 GENE; S100A7 GENE; S100A8 GENE; S100A9 GENE; TUMOR GENE; UPREGULATION; CARCINOMA, SQUAMOUS CELL; CASE CONTROL STUDY; CHROMOSOME 1; GENE EXPRESSION REGULATION; GENETICS; HEAD AND NECK NEOPLASMS; METABOLISM; MIDDLE AGED;

CORNIFIED ENVELOPE LIKE PROLINE RICH PROTEIN; LCE3D PROTEIN, HUMAN; MESSENGER RNA; PROTEIN S 100; TUMOR MARKER;

CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 1; CORNIFIED ENVELOPE PROLINE-RICH PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC LOCI; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; RNA, MESSENGER; S100 PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 84904111269     PISSN: 02398508     EISSN: 18975631     Source Type: Journal    
DOI: 10.5603/FHC.2014.0018     Document Type: Article

References (66)

1. Kypriotou M, Huber M, Hohl D. The human epidermal differentiation complex: cornified envelope precursors, S100 proteins and the "fused genes" family. Exp Dermatol. 2012; 21: 643-649.
2. Kimchi ET, Posner MC, Park JO et al. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation. Cancer Res. 2005; 65: 3146-3154.
3. Zucchini C, Biolchi A, Strippoli Pet et al. Expression profile of epidermal differentiation complex genes in normal and anal cancer cells. Int J Oncol. 2001; 19: 1133-1141.
4. Srikrishna G, Freeze HH. S100 protein family and tumorigenesis. Available at: http: //atlasgeneticsoncology.org/Deep/ /S100ProtFamilyTumorID20092.html. Accessed June, 2014.
5. Salama I, Malone PS, Mihaimeed F, Jones JL. A review of the S100 proteins in cancer. Eur J Surg Oncol. 2008; 34: 357-364.
6. Sherbet GV. Metastasis promoter S100A4 is a potentially valuable molecular target for cancer therapy. Cancer Lett. 2009; 280: 15-30.
7. Mishra SK, Siddique HR, Saleem M. S100A4 calcium-binding protein is key player in tumor progression and metastasis: preclinical and clinical evidence. Cancer Metastasis Rev. 2012; 31: 163-172.
8. Kesting MR, Stoeckelhuber M, Kuppek A et al. Human b-defensins and psoriasin/S100A7 expression in salivary glands: anti-oncogenic molecules for potential therapeutic approaches. BioDrugs. 2012; 26: 33-42.
9. Jackson B, Tilli CM, Hardman MJ et al. Late cornified envelope family in differentiating epithelia-response to calcium and ultraviolet irradiation. J Invest Dermatol. 2005; 124: 1062-1070.
10. Tsai ST, Jin YT, Tsai WC et al. S100A2, a potential marker for early recurrence in early-stage oral cancer. Oral Oncol. 2005; 41: 349-357.
11. Suzuki F, Oridate N, Homma A et al. S100A2 expression as a predictive marker for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral cavity. Oncol Rep. 2005; 14: 1493-1498.
12. Lauriola L, Michetti F, Maggiano N et al. Prognostic significance of the Ca(2+) binding protein S100A2 in laryngeal squamous-cell carcinoma. Int J Cancer. 2000; 89: 345-349.
13. Lohman FP, Medema JK, Gibbs S, Ponec M, van de Putte P, Backendorf C. Expression of the SPRR cornification genes is differentially affected by carcinogenic transformation. Exp Cell Res. 1997; 231: 141-148.
14. Lemaire F, Millon R, Young J et al. Differential expression profiling of head and neck squamous cell carcinoma (HNSCC). Br J Cancer. 2003; 89: 1940-1949.
15. Hudson LG, Gale JM, Padilla RS et al. Microarray analysis of cutaneous squamous cell carcinomas reveals enhanced expression of epidermal differentiation complex genes. Mol Carcinog. 2010; 49: 619-629.
16. Markowski J, Oczko-Wojciechowska M, Gierek T et al. Gene expression profile analysis in laryngeal cancer by high-density oligonucleotide microarrays. J Physiol Pharmacol. 2009; 60: 57-63.
17. Jarzab J, Filipowska B, Zebracka J et al. Locus 1q21 Gene expression changes in atopic dermatitis skin lesions: deregulation of small proline-rich region 1A. Int Arch Allergy Immunol. 2010; 151: 28-37.
18. de Oliveira MV, de Carvalho Fraga CA, Barros LO et al. High expression of S100A4 and endoglinis associated with metastatic disease in head and neck squamous cell carcinoma. ClinExp Metastasis. 2014. May 6 [Epub ahead of print].
19. Albuquerque RLC, Miguel MCC, Costa ALL, Souza LB. Correlation of c-erbB-2 and S-100 expression with the malignancy grading and anatomical site in oral squamous cell carcinoma. Int J Exp Pathol. 2003; 84: 259-265.
20. DeRycke MS, Andersen JD, Harrington KM et al. S100A1 expression in ovarian and endometrial endometrioid carcinomas is a prognostic indicator of relapse-free survival. Am J Clin Pathol. 2009; 132: 846-856.
21. Sapkota D, Bruland O, Bøe OE et al. Expression profile of the S100 gene family members in oral squamous cell carcinomas. J Oral Pathol Med. 2008; 37: 607-615.
22. Grigorian M, Andresen S, Tulchinsky E et al. Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction. J Biol Chem. 2001; 276: 22 699-22 708.
23. Lee SJ, Choi SY, Kim WJ et al. Combined aberrant expression of E-cadherin and S100A4, but not b-catenin is associated with disease-free survival and overall survival in colorectal cancer patients. Diagn Pathol. 2013; 8: 99.
24. Jia W, Gao XJ, Zhang ZD, Yang ZX, Zhang G. S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF. Eur Rev Med Pharmacol Sci. 2013; 17: 1495-1508.
25. Kozono S, Ohuchida K, Ohtsuka T et al. S100A4 mRNA expression level is a predictor of radioresistance of pancreatic cancer cells. Oncol Rep. 2013; 30: 1601-1608.
26. Emberley ED, Murphy LC, Watson PH. S100A7 and the progression of breast cancer. Breast Cancer Res. 2004; 6: 153-159.
27. Wetting HL, Hadler-Olsen E, Magnussen S et al. S100A4 expression in xenograft tumors of human carcinoma cell lines is induced by the tumor microenvironment. Am J Pathol. 2011; 178: 2389-2396.
28. Nakashima T, Yano G, Hayashi I, Katsuta Y. Epithelial membrane antigen and S-100 protein-labeled cells in primary and metastatic laryngeal carcinomas. Head Neck. 1992; 14: 445-451.
29. Shrestha P, Muramatsu Y, Kudeken W et al. Localization of Ca(2+)-binding S100 proteins in epithelial tumours of the skin. Virchows Arch. 1998; 4324: 53-59.
30. Moriyama-Kita M, Endo Y, Yonemura Y et al. S100A4 regulates E-cadherin expression in oral squamous cell carcinoma. Cancer Lett. 2005; 230: 211-218.
31. Moriyama-Kita M, Endo Y, Yonemura Y et al. Correlation of S100A4 expression with invasion and metastasis in oral squamous cell carcinoma. Oral Oncol. 2004; 401: 496-500.
32. Lo JF, Yu CC, Chiou SH et al. The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers. Cancer Res. 2011; 711: 1912-1923.
33. Kennedy RD, Gorski JJ, Quinn JE et al. BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a DNA damage-inducible gene. Cancer Res. 2005; 65: 10 265-10 272.
34. Tiveron RC, de Freitas LC, Figueiredo DL, Serafini LN, Mamede RC, Zago MA. Expression of calcium binding protein S100 A7 (psoriasin) in laryngeal carcinoma. Braz J Otorhinolaryngol. 2012; 78: 59-65.
35. Tripathi SC, Matta A, Kaur J et al. Nuclear S100A7 is associated with poor prognosis in head and neck cancer. PLoS One. 2010; 5: e11939.
36. Winter J, Pantelis A, Reich R et al. Risk estimation for a malignant transformation of oral lesions by S100A7 and Doc-1 gene expression. Cancer Invest. 2011; 29: 478-484.
37. Anania MC, Miranda C, Vizioli MG et al. S100A11 overexpression contributes to the malignant phenotype of papillary thyroid carcinoma. J Clin Endocrinol Metab. 2013; 98: E1591-E1600.
38. Hilly O, Koren R, Raz R et al. The role of s100-positive dendritic cells in the prognosis of papillary thyroid carcinoma. Am J Clin Pathol. 2013; 139: 87-92.
39. Wang C, Zhang Z, Li L et al. S100A11 is a migration-related protein in laryngeal squamous cell carcinoma. Int J Med Sci. 2013; 10: 1552-1559.
40. Wolf S, Haase-Kohn C, Pietzsch J. S100A2 in cancerogenesis: a friend or a foe? Amino Acids. 2011; 41: 849-861.
41. Bachet JB, Maréchal R, Demetter P et al. S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinoma. Eur J Cancer. 2013; 49: 2643-2653.
42. Chattopadhyay I, Singh A, Phukan R et al. Genome-wide analysis of chromosomal alterations in patients with esophageal squamous cell carcinoma exposed to tobacco and betel quid from high-risk area in India. Mutat Res. 2010; 696: 130-138.
43. Liu B, Sun WY, Zhi CY et al. Role of S100A3 in human colorectal cancer and the anticancer effect of cantharidinate. Exp Ther Med. 2013; 6: 1499-1503.
44. Yao R, Lopez-Beltran A, Maclennan GT, Montironi R, Eble JN, Cheng L. Expression of S100 protein family members in the pathogenesis of bladder tumors. Anticancer Res. 2007; 27: 3051-3058.
45. Liu J, Li X, Dong GL et al. In silico analysis and verification of S100 gene expression in gastric cancer. BMC Cancer. 2008; 8: 261.
46. Ehrchen JM, Sunderkötter C, Foell D, Vogl T, Roth J. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol. 2009; 86: 557-566.
47. Cormier K, Harquail J, Ouellette RJ, Tessier PA, Guerrette R, Robichaud GA. Intracellular expression of inflammatory proteins S100A8 and S100A9 leads to epithelial-mesenchymal transition and attenuated aggressivity of breast cancer cells. Anticancer Agents Med Chem. 2013; 14: 35-45.
48. Duan L, Wu R, Ye L et al. S100A8 and S100A9 are associated with colorectal carcinoma progression and contribute to colorectal carcinoma cell survival and migration via Wnt/b-catenin pathway. PLoS One. 2013; 8: e62092.
49. Driemel O, Escher N, Ernst G, Melle C, von Eggeling F. S100A8 cellular distribution in normal epithelium, hyperplasia, dysplasia and squamous cell carcinoma and its concentration in serum. Anal Quant Cytol Histol. 2010; 32: 219-224.
50. Ghavami S, Chitayat S, Hashemi M et al. S100A8/A9: a Janus-faced molecule in cancer therapy and tumorgenesis. Eur J Pharmacol. 2009; 625: 73-83.
51. Yang X, Wei K-J, Zhang L et al. Decreased expression of S100A6 in oral squamous cell carcinoma. Oncol Rep. 2010; 24: 479-488.
52. Leśniak W, Słomnicki ŁP, Kuźnicki J. Epigenetic control of the S100A6 (calcyclin) gene expression. J Invest Dermatol. 2007; 127: 2307-2314.
53. Leśniak W, Słomnicki ŁP, Filipek A. S100A6-new facts and features. Biochem Biophys Res Commun. 2009; 390: 1087-1092.
54. Sapkota D, Bruland O, Costea DE, Haugen H, Vasstrand EN, Ibrahim SO. S100A14 regulates the invasive potential of oral squamous cell carcinoma derived cell-lines in vitro by modulating expression of matrix metalloproteinases, MMP1 and MMP9. Eur J Cancer. 2011; 47: 600-610.
55. Sapkota D, Costea DE, Ibrahim SO, Johannessen AC, Bruland O. S100A14 Interacts with S100A16 and Regulates Its Expression in Human Cancer Cells. PLoS One. 2013; 8: e76058.
56. Citi S, Amorosi A, Franconi F, Giotti A, Zampi G. Cingulin, a specific protein component of tight junctions, is expressed in normal and neoplastic human epithelial tissues. Am J Pathol. 1991; 138: 781-789.
57. Lee HS, Daar IO. EphrinB reverse signaling in cell-cell adhesion: is it just par for the course? Cell Adh Migr. 2009; 3: 250-255.
58. Demetris AJ, Specht S, Nozaki I et al. Small proline-rich proteins (SPRR) function as SH3 domain ligands, increase resistance to injury and are associated with epithelial-mesenchymal transition (EMT) in cholangiocytes. J Hepatol. 2008; 48: 276-288.
59. De Heller-Milev M, Huber M, Panizzon R, Hohl D. Expression of small proline rich proteins in neoplastic and inflammatory skin diseases. Br J Dermatol. 2000; 143: 733-740.
60. Ellis T, Smyth I, Riley E et al. Overexpression of Sonic Hedgehog suppresses embryonic hair follicle morphogenesis. Dev Biol. 2003; 263: 203-215.
61. Niderla-Bielińska J, Moskalewski S. Involucrin, but not filaggrin and Kdap mRNA, expression is downregulated in 3-D cultures of intact rat hair bulbs after calcium stimulation. Folia Histochem Cytobiol. 2011; 49: 335-343.
62. Thiel UJE, Feltens R, Adryan B et al. Analysis of differentially expressed proteins in oral squamous cell carcinoma by MALDI-TOF MS. J Oral Pathol Med. 2011; 40: 369-379.
63. Odani T, Ito D, Li MH et al. Gene expression profiles of oral leukoplakia and carcinoma: genome-wide comparison analysis using oligonucleotide microarray technology. Int J Oncol. 2006; 28: 619-624.
64. Lim SC, Zhang S, Ishii G et al. Predictive markers for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral tongue. Clin Cancer Res. 2004; 10: 166-172.
65. Shruthy R, Sharada P, Swaminathan U, Nagamalini B. Immunohistochemical expression of basement membrane laminin in histological grades of oral squamous cell carcinoma: A semiquantitative analysis. J Oral Maxillofac Pathol. 2013; 17: 185-189.
66. Osiecka BJ, Marciniak Z, Jeleń M, Bowszyc-Dmochowska M. Evaluation of laminin and cytokeratin-10 expression in squamous cell carcinoma of the skin. Folia Histochem Cytobiol. 1997; 35: 121-122.